Show all images
Pharmacosmos - CDMO/CMO
Pharmacosmos specialises in the development and manufacturing of dextran-based products, providing services such as synthesis development, customization, derivatization, fractionation, scale-up, and commercial production. These services are designed to deliver tailored solutions that meet specific client needs, ensuring high purity, efficacy, and safety. With a commitment to quality and innovation, Pharmacosmos supports pharmaceutical, biotech, and veterinary companies in bringing dextran-based products to market efficiently and confidently.
Our CDMO services are customized to address your unique requirements, from custom synthesis and derivatization to optimizing production and ensuring regulatory compliance. From lab-scale optimisation and pilot projects to full-scale commercial production, we work closely with you to co-create solutions that align with your unique needs.
With...
Denmark
Local time:
Global leader in carbohydrate manufacturing and dextran fractionation techniques
cGMP facility inspected by EMA and FDA
Synthesis, customization, derivatization, fractionation of Dextran/Dextran Derivatives
Our services:
Production scale:
Response time:
Follow us:
Latest updates
PentaHibe® Complete, ready-to-use cryopreservation medium
Learn more
Pharmacosmos successfully registers dextran 40 and 70 as excipients in China
Learn moreDrug Substance (CDMO/CRO)
Replies quickly
Replies quickly
Contact Pharmacosmos for Contract Services Expertise
Connect with Pharmacosmos, a leading pharmaceutical company from Denmark. They offer specialized Drug Substance (CDMO/CRO). Contact Pharmacosmos for free and discover if they are the perfect partner for your pharmaceutical needs.
Drug Substance (CDMO/CRO)
Drug Substance CDMOs and CROs provide essential services in the development and manufacturing of active pharmaceutical ingredients (APIs). These organizations specialize in early-stage research, process development, and GMP-compliant manufacturing of drug substances for clinical and commercial use.
Pharmaoffer's Drug Substance CDMO/CRO category includes partners with expertise in small molecules, biologics, peptides, and complex chemistry, all operating under strict regulatory compliance. These providers help companies scale from lab to market efficiently and cost-effectively.
Key Functions of Drug Substance CDMOs/CROs:
API Research and Development: Providing early-stage discovery support, custom synthesis, and process optimization to streamline the development of drug substances.
Process Scale-Up and Tech Transfer: Transitioning from bench-scale to pilot and commercial scale production with validated methods and reproducibility.
GMP Manufacturing: Delivering high-quality API batches in GMP-certified environments, adhering to FDA, EMA, and other international standards.
Analytical Services: Offering comprehensive analytical method development and validation to ensure consistent quality and regulatory compliance.
Flexible and Specialized Capabilities: From small molecule synthesis to biologic and peptide manufacturing, these partners provide specialized services tailored to product-specific needs.
Explore Leading API CDMOs and CROs
Pharmaoffer connects you with trusted CDMOs and CROs for drug substance development. Our platform enables seamless access to specialized service providers equipped to support your API lifecycle from discovery to commercialization.